| Product Code: ETC7542046 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Drug Development Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Drug Development Market Revenues & Volume, 2021 & 2031F |
3.3 India Drug Development Market - Industry Life Cycle |
3.4 India Drug Development Market - Porter's Five Forces |
3.5 India Drug Development Market Revenues & Volume Share, By Mode, 2021 & 2031F |
3.6 India Drug Development Market Revenues & Volume Share, By Process Step, 2021 & 2031F |
3.7 India Drug Development Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
4 India Drug Development Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in research and development by pharmaceutical companies in India |
4.2.2 Growing prevalence of chronic diseases driving the demand for new drugs |
4.2.3 Government initiatives to promote indigenous drug development and innovation |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and lengthy approval processes |
4.3.2 High costs associated with drug development and clinical trials |
5 India Drug Development Market Trends |
6 India Drug Development Market, By Types |
6.1 India Drug Development Market, By Mode |
6.1.1 Overview and Analysis |
6.1.2 India Drug Development Market Revenues & Volume, By Mode, 2021- 2031F |
6.1.3 India Drug Development Market Revenues & Volume, By In house, 2021- 2031F |
6.1.4 India Drug Development Market Revenues & Volume, By Outsourced, 2021- 2031F |
6.2 India Drug Development Market, By Process Step |
6.2.1 Overview and Analysis |
6.2.2 India Drug Development Market Revenues & Volume, By Process Research Development, 2021- 2031F |
6.2.3 India Drug Development Market Revenues & Volume, By Formulation, 2021- 2031F |
6.2.4 India Drug Development Market Revenues & Volume, By Analytical & Stability Studies, 2021- 2031F |
6.2.5 India Drug Development Market Revenues & Volume, By DMPK, 2021- 2031F |
6.2.6 India Drug Development Market Revenues & Volume, By Safety Assessment (Toxicology), 2021- 2031F |
6.2.7 India Drug Development Market Revenues & Volume, By Regulatory Compliance, 2021- 2031F |
6.3 India Drug Development Market, By Therapeutic Area |
6.3.1 Overview and Analysis |
6.3.2 India Drug Development Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.3 India Drug Development Market Revenues & Volume, By Inflammation & Immunology, 2021- 2031F |
6.3.4 India Drug Development Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.3.5 India Drug Development Market Revenues & Volume, By Neuroscience, 2021- 2031F |
6.3.6 India Drug Development Market Revenues & Volume, By Others, 2021- 2031F |
7 India Drug Development Market Import-Export Trade Statistics |
7.1 India Drug Development Market Export to Major Countries |
7.2 India Drug Development Market Imports from Major Countries |
8 India Drug Development Market Key Performance Indicators |
8.1 Number of patents filed for new drug molecules in India |
8.2 Percentage of clinical trials conducted in India compared to other countries |
8.3 Investment trends in research and development within the Indian pharmaceutical industry |
9 India Drug Development Market - Opportunity Assessment |
9.1 India Drug Development Market Opportunity Assessment, By Mode, 2021 & 2031F |
9.2 India Drug Development Market Opportunity Assessment, By Process Step, 2021 & 2031F |
9.3 India Drug Development Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
10 India Drug Development Market - Competitive Landscape |
10.1 India Drug Development Market Revenue Share, By Companies, 2024 |
10.2 India Drug Development Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here